Skip to main content

Table 5 Statistical comparison of delta changes (Δ) according to groups

From: Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation

Measurements

Group

p comparision

Group1

Group2

Group3

Δ

Δ

Δ

BCVA

47% G1

21%G2

32%G3

0.01* G1 > G3 > G2

Visual field FPDI

95%G1

33%G2

27%G3

0.01* G1 > G2 > G3

GCC thickness

 − 21%G1

 − 13%G2

 − 15%G3

0.01* G1 > G3 > G2

VEP P100 lat

 − 18%G1

 − 8%G2

 − 10%G3

0.01* G1 > G3 > G2

VEP P100 ampl

105%G1

24%G2

83%G3

0.01* G1 > G3 > G2

  1. Δ rate of change was calculated as the last-first measurement / first measurement. **(Sidak comparision test, *p < 0.05: statistically signifficant)
  2. BCVA best corrected visual acuity (ETDRS letters), FPDI fundus perimetry deviation index (%), GCC thickness Ganglion cell complex (µm), VEP visual evoked potential, P100 lat latency (ms), P100 ampl amplitude (mV)